Using higher doses to compensate for tubing residuals in extended-infusion piperacillin-tazobactam

WJ Lam, T Bhowmick, A Gross… - Annals of …, 2013 - journals.sagepub.com
OBJECTIVE: To mathematically assess drug losses due to infusion line residuals and
evaluate methods to compensate for drug loss due to residual volumes in intravenous pump …

Ensuring an appropriate ethics oversight under the new EU Clinical Trial Regulation: challenges and practicalities

J Glasa, H Glasová - Clinical Therapeutics, 2017 - clinicaltherapeutics.com
Background: Imipenem is a broad-spectrum β-lactam antibiotic frequently used for infectious
complications in ICU patients. Dosing optimisation still remains challenging for clinicians …

Dosing of piperacillin/tazobactam in a morbidly obese patient

H Deman, J Verhaegen, L Willems… - Journal of antimicrobial …, 2012 - academic.oup.com
Sir, The combination of piperacillin and tazobactam has been shown to be efficacious for the
treatment of intra-abdominal infections, skin and soft tissue infections, bacteraemia and …

Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients

N Patel, MH Scheetz, GL Drusano… - Antimicrobial agents and …, 2010 - Am Soc Microbiol
This study examined the effect of various levels of renal impairment on the probability of
achieving free drug concentrations that exceed the MIC for 50% of the dosing interval (50% f …

Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational study

H Aardema, PN Panday, M Wessels… - International journal of …, 2017 - Elsevier
Optimal dosing of β-lactam antibiotics in critically ill patients is a challenge given the
unpredictable pharmacokinetic profile of this patient population. Several studies have shown …

[引用][C] Target controlled infusion versus traditional delivery of piperacillin: a computer model comparison

MA Horton, IH Black - Proceedings of the 2009 annual meeting of the …, 2009

An integral pharmacokinetic analysis of piperacillin and tazobactam in plasma and urine in critically ill patients

E Wallenburg, R Ter Heine, JA Schouten… - Clinical …, 2022 - Springer
Abstract Background and Objectives Although dose optimization studies have been
performed for piperacillin and tazobactam separately, a combined integral analysis is not yet …

Piperacillin‐tazobactam pharmacokinetics in patients with intraabdominal infections

SS Jhee, JW Kern, JP Burm, AE Yellin… - … : The Journal of …, 1995 - Wiley Online Library
Study Objective. To determine the appropriate compartmental and noncompartmental
pharmacokinetic parameters for intravenous piperacillin and tazobactam. Design …

Population pharmacokinetics of piperacillin following continuous infusion in critically ill patients and impact of renal function on target attainment

V Klastrup, A Thorsted, M Storgaard… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Pharmacokinetic changes are often seen in patients with severe infections. Administration
by continuous infusion has been suggested to optimize antibiotic exposure and …

Predictive performance of physiologically based pharmacokinetic modelling of beta-lactam antibiotic concentrations in adipose, bone, and muscle tissues

PJ De Sutter, P De Cock, TN Johnson, H Musther… - Drug Metabolism and …, 2023 - ASPET
Physiologically based pharmacokinetic (PBPK) models consist of compartments
representing different tissues. As most models are only verified based on plasma …